A new breed of drugs that reduces the number of deaths from bladder cancer could also replace chemotherapy treatment for other types of cancers. Early research with the ADC drug enfortumab vedotin on bladder cancer has already shown it to cut deaths by a third – and trials are under way to test the effectiveness of the experimental therapy on breast and prostate cancer. 'ADCs are able to transport cancer-killing drugs directly to the cancer cells with limited effect on the rest of the body. Every year, more than 10,000 Britons are diagnosed with bladder cancer. But, over time, all treatments become ineffective against bladder cancer.

Source: Daily Mail March 20, 2021 22:15 UTC